Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.
about
Multiple Bacteriophage Selection Strategies for Improved Affinity of a Peptide Targeting ERBB2High-Throughput Approaches to the Development of Molecular Imaging Agents.Targeted nanodiamonds as phenotype-specific photoacoustic contrast agents for breast cancer.In vivo photoacoustic imaging of breast cancer tumor with HER2-targeted nanodiamondsMolecular imaging agents: impact on diagnosis and therapeutics in oncologyCombinatorial peptide libraries: mining for cell-binding peptides.Phage display in molecular imaging and diagnosis of cancer.Phage display and molecular imaging: expanding fields of vision in living subjects.A fluorescent protein scaffold for presenting structurally constrained peptides provides an effective screening system to identify high affinity target-binding peptides.In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomasPhage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas."One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncologyDevelopment of a peptide-drug conjugate for prostate cancer therapy.Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancerSynthesis and characterization of Her2-NLP peptide conjugates targeting circulating breast cancer cells: cellular uptake and localization by fluorescent microscopic imaging.Tumor-targeting peptides from combinatorial libraries.Design and development of molecular imaging probes.Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody moleculesPolymersomes and their applications in cancer delivery and therapy.Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells.In vivo bacteriophage peptide display to tailor pharmacokinetics of biological nanoparticles.Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.Bifunctional phage-based pretargeted imaging of human prostate carcinoma.Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides.[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model.
P2860
Q28393445-4CDF090D-E9D6-43DF-A973-27BF7BC1E003Q30275493-BC98BC29-34D5-48F3-A81F-FCE23F881471Q30389883-C7D9A380-AD86-4D2C-85E6-6BAC40702CCFQ30420459-12F27BA1-26CC-4F71-B74F-C04499E41F3CQ30433423-106105B0-A3B2-488C-8152-69A30E208873Q31144876-B2501C26-0500-4FE8-B8F7-E90452DAA7FEQ33532734-DE95DBDD-FDA3-4816-AE5B-A5474D63B61CQ33849788-75577390-5519-4796-A4D8-7028C45531DDQ33989074-26CF3724-48FC-4A10-87BA-023EC477CE91Q34210188-D9D5C273-B0C1-4B62-85BD-F5E2D7CEC05CQ34273411-7C7836EC-7A7C-484D-BB10-299E32CE5FBDQ34519479-00C2FA14-3D90-43A0-8532-F1FCD28C57BAQ35055942-536817FD-68CB-449B-B7B4-52524E0DF8E0Q35184864-B1BC3094-CA23-406F-A8A3-FC52085C8DAFQ35229181-55AC8983-5D9C-4283-BCE5-7AB6B744CF08Q35548992-0A86F9BC-0F8C-4001-8756-3C3C86477AF9Q36025723-A9A8B626-A0EC-425C-B55A-A8FC92701BC5Q36785137-4022EAB3-11A4-4541-A1ED-2889A99959ECQ36922818-777E32C8-7947-407A-B1CF-70605082E969Q38578305-57299F66-7B1E-4E53-B19D-B3BD07DAED36Q38716531-14D47D49-0D1F-446A-8137-C043DD3A1AB1Q38718538-B032FC99-1BA2-4A2F-98AE-90AA12F73021Q38977436-CDAD17FD-64C3-4905-A0B0-1AEB7CE713F0Q39022761-24EAD79C-31B3-49BC-AE50-F3E625682A55Q39805831-9A7B6EE9-13FC-4D0B-936E-0E16705A725CQ44262180-761C5A33-19C2-4F5F-AEB6-40C643F4A86CQ44448280-CB5A8156-7AE1-4A8B-936C-20188713BF6F
P2860
Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Evaluation of an 111In-radiola ...... expressing breast carcinomas.
@en
type
label
Evaluation of an 111In-radiola ...... expressing breast carcinomas.
@en
prefLabel
Evaluation of an 111In-radiola ...... expressing breast carcinomas.
@en
P2093
P1476
Evaluation of an 111In-radiola ...... expressing breast carcinomas.
@en
P2093
Senthil R Kumar
Susan L Deutscher
Thomas P Quinn
P304
P356
10.1158/1078-0432.CCR-07-0160
P407
P577
2007-10-01T00:00:00Z